J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
Medicines by ATC code J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
- Baraclude Patient leaflet Summary of medicine characteristics
- Ziagen Patient leaflet Summary of medicine characteristics
- Tenofovir disoproxil Zentiva Patient leaflet Summary of medicine characteristics
- Lamivudine Teva Pharma B.V. Patient leaflet Summary of medicine characteristics
- Vemlidy Patient leaflet Summary of medicine characteristics
- Lamivudine Teva Patient leaflet Summary of medicine characteristics
- Entecavir Accord Patient leaflet Summary of medicine characteristics
- Zeffix Patient leaflet Summary of medicine characteristics
- Epivir Patient leaflet Summary of medicine characteristics
- Tenofovir disoproxil Mylan Patient leaflet Summary of medicine characteristics
- Emtriva Patient leaflet Summary of medicine characteristics
- Viread Patient leaflet Summary of medicine characteristics
- Hepsera Patient leaflet Summary of medicine characteristics
- Entecavir Mylan Patient leaflet Summary of medicine characteristics
- Sebivo Patient leaflet Summary of medicine characteristics
- Zerit Patient leaflet Summary of medicine characteristics
Other names of the ATC group
- Czech: J05AF Nukleosidové a nukleotidové inhibitory reverzní transkriptázy
- French: J05AF inhibiteurs de la transcriptase reverse nucléosidiques et nucléotidiques
- German: J05AF Nukleosidale und nukleotidale Inhibitoren der Reversen Transkriptase
- German: J05AF Nukleosidale und nukleotidale Inhibitoren der Reversen Transkriptase
- Italian: J05AF Nucleosidi e nucleotidi inibitori della transcrittasi inversa
- Polish: J05AF Nukleozydowe i nukleotydowe inhibitory odwrotnej transkryptazy
- Turkish: J05AF Nükleozid ve nükleotid ters transkriptaz inhibitörleri
- Portuguese (Brazil): J05AF Nucleosídeos e nucleotídeos inibidores da transcriptase reversa